Quoin Pharmaceuticals QNRX Cash Flow Statement (2020-2026)

NASDAQ QNRX
$3.90 +0.27 (+7.44%)
At close: Nov 9, 2026 · 4:00 PM EST
Reported Financials

Quoin Pharmaceuticals Quarterly Cash Flow Statement

Periods 23 quarters
Latest Sep 2026

Quoin Pharmaceuticals reported cash from operations of -$5.77M and free cash flow of -$5.77M for the quarter ended Sep 2026, down 159.3% year over year. This cash flow statement covers 23 quarters of results from Dec 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2020 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-11.82M-1.68M-2.67M-3.03M-2.00M-2.60M-2.11M-1.93M-2.05M-2.33M-1.97M-2.35M-2.31M-3.81M-3.70M-3.95M-4.35M-5.00M-5.37M-4.87M
Depreciation, Depletion & Amortization
Amortization of IntangiblesAmort. of Intangibles
0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M
Share-based CompensationStock Comp.
0.23M0.27M0.27M0.26M0.26M0.27M0.30M0.31M0.31M0.31M0.33M0.36M0.32M0.18M0.29M0.45M0.53M0.48M
Gains from Investment SecuritiesGains Investment
0.08M0.13M0.10M0.14M0.12M0.10M0.02M0.07M0.07M0.07M
Other non-cash itemsOther Non-Cash
8.26M-0.49M
Change in Working Capital
Change in Accrued ExpensesChange Accrued Exp.
0.89M0.16M0.28M-0.59M-0.07M0.58M0.18M0.29M-1.00M0.64M-0.27M-0.48M0.38M0.67M-0.52M1.43M-0.26M-0.20M1.27M-0.95M
Change in Other Operating AssetsOther Assets Change
-0.21M0.02M-0.33M0.40M-0.12M-0.16M-0.16M0.40M-0.02M0.08M-0.38M0.60M-0.23M-0.26M-0.09M0.66M0.03M-0.46M0.42M
Other Working Capital ChangesOther WC Changes
0.21M-0.02M0.33M-0.40M0.12M0.16M0.16M-0.40M0.02M-0.08M0.38M-0.60M0.23M0.26M0.09M-0.66M-0.03M0.46M-0.42M
Cash from OperationsCash from Ops.
-3.18M-2.09M-2.15M-2.29M-1.94M-1.75M-1.57M-1.32M-3.22M-1.43M-2.01M-2.18M-2.24M-2.59M-3.69M-2.23M-5.04M-4.87M-3.14M-5.77M
Investing Activities
Purchase of InvestmentsInvestments Purchased
13.49M4.60M9.65M1.61M6.00M0.98M0.98M21.09M
Sale and Maturity of InvestmentsInvestments Sold
10.00M3.04M4.60M2.64M5.18M3.16M4.21M2.82M2.77M1.68M2.54M1.00M5.10M5.00M5.00M
Cash from Investing ActivitiesCash from Investing
-0.25M-0.05M-0.20M-9.90M-3.49M3.04M821.002.64M-4.47M3.16M2.60M-3.18M2.77M1.68M2.54M-11.27M4.12M4.02M-16.09M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
0.14M
Long-Term Debt RepaymentsLT Debt Repayment
0.15M0.15M0.15M0.15M0.46M0.10M0.08M0.28M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M
Net Long-Term Debt Issued (Repaid)Net LT Debt
-0.01M-0.15M-0.15M-0.15M-0.46M-0.10M-0.08M-0.28M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.01M-0.15M-0.15M-0.15M-0.46M-0.10M-0.08M-0.28M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M
Change in Capital Stock
Common Stock IssuedStock Issued
-0.03M5.85M5.48M0.01M108.006.07M0.17M18.44M0.21M0.00M28.26M
Net Shares Issued and RepurchasedNet Shares Issued
-0.03M5.85M5.48M0.01M108.006.07M0.17M18.44M0.21M0.00M28.26M
Net Equity Issued and RepurchasedNet Equity Issued
-0.03M5.85M5.48M0.01M108.006.07M0.17M18.44M0.21M0.00M28.26M
Other financing activities (as filed)
Cash from Financing ActivitiesCash from Financing
10.26M-0.15M-0.15M14.75M-0.45M5.75M-0.08M-0.28M-0.18M5.33M-0.14M-0.15M5.92M0.02M-0.15M-0.15M18.29M0.06M-0.15M28.11M
Additional items
Exchange Rate EffectFX Effect
454.00-423.000.00M
Change in Cash
6.83M-2.29M-2.50M2.56M-2.39M0.51M1.39M-1.60M-0.76M-0.57M1.01M0.27M0.51M0.20M-2.15M0.16M1.99M-0.69M0.72M6.25M
Ending Cash Balance
7.48M5.19M2.69M5.25M2.86M3.37M4.76M3.16M2.40M1.83M2.85M3.12M3.62M3.82M1.67M1.83M3.82M3.12M3.85M10.10M
Free Cash FlowFCF
-3.18M-2.09M-2.15M-2.29M-1.94M-1.75M-1.57M-1.32M-3.22M-1.43M-2.01M-2.18M-2.24M-2.59M-3.69M-2.23M-5.04M-4.87M-3.14M-5.77M
Net Cash FlowNCF
6.83M-2.29M-2.50M2.56M-2.39M0.51M1.39M-1.60M-0.76M-0.57M1.01M0.27M0.51M0.20M-2.15M0.16M1.99M-0.69M0.72M6.25M

Quoin Pharmaceuticals Cash Flow Statement API

Pull Quoin Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=QNRX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY